Registration Fees

Registration details for the 2023 course will be posted soon.

REGISTER EARLY AND SAVE!

This Course Will Be Live-Streamed

Special pricing is in effect for this program.

This course will be live-streamed and includes real-time audience-response questions, live demonstrations and interactive Q&A sessions allowing you to pose specific questions to our expert faculty via online chat. All presentations and course materials will be available immediately to watch and review at your convenience.

All live-stream sessions are eligible for AMA PRA Category 1 Credits™ and ABIM MOC points, as well as other relevant CME credits.

FOLLOW US ON FACEBOOK

Upon completion of this course, participants will be able to:

Describe how advances in our understanding of pathophysiology and natural progression of type 1 and type 2 diabetes have resulted in a more integrated consideration of comorbidities into the design of glycemic treatments.
Identify strategies to optimize the impact of lifestyle interventions in the treatment of diabetes and related conditions.
Summarize appropriate, evidence-based treatment guidelines from recognized, expert organizations for the treatment of diabetes.
Discuss new and evolving pharmacologic and electronic tools that currently or potentially impact the treatment design, efficacy, and/or safety of glycemic control programs.
Demonstrate skills in advancing therapies for glycemic control aimed at achieving recommended treatment targets.
Identify strategies to care for patients with diabetes-related comorbidities and complications based on updated knowledge of state-of-the-art treatment advances.
Explain strategies to identify and then overcome clinical practice barriers emanating from patients, providers, and practice systems issues.
Communicate with patients, families, and health team members in a responsive manner that supports a team approach to the promotion and maintenance of health and prevention and treatment of disease in individuals with diabetes.